# FDA Inspection 1042813 - Alaris Biologic Technologies, Inc. - March 02, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/alaris-biologic-technologies-inc/8f6aa040-31e0-4c5b-b564-63639f159319
Source feed: FDA_Inspections

> FDA Inspection 1042813 for Alaris Biologic Technologies, Inc. on March 02, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1042813
- Company Name: Alaris Biologic Technologies, Inc.
- Inspection Date: 2018-03-02
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1042813 - 2018-03-02](https://www.globalkeysolutions.net/records/fda_inspections/alaris-biologic-technologies-inc/886fc516-106b-4e47-8bfa-f3d2321b063b)
- [FDA Inspection 987207 - 2016-04-29](https://www.globalkeysolutions.net/records/fda_inspections/alaris-biologic-technologies-inc/515dc2ee-3f99-4203-abfa-afd2653a3679)
- [FDA Inspection 926000 - 2015-05-13](https://www.globalkeysolutions.net/records/fda_inspections/alaris-biologic-technologies-inc/9d333107-5791-4255-bd65-384d868665e4)

Company: https://www.globalkeysolutions.net/companies/alaris-biologic-technologies-inc/7d9d6418-d831-4366-868c-560f1ff92452

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d